DE19575006I2 - 1, 2, 3, 4a, 5, 10, 10a-Octahydrobenzo(g)chinolin-Derivate mit pharmazeutischer Wirkung - Google Patents

1, 2, 3, 4a, 5, 10, 10a-Octahydrobenzo(g)chinolin-Derivate mit pharmazeutischer Wirkung

Info

Publication number
DE19575006I2
DE19575006I2 DE1995175006 DE19575006C DE19575006I2 DE 19575006 I2 DE19575006 I2 DE 19575006I2 DE 1995175006 DE1995175006 DE 1995175006 DE 19575006 C DE19575006 C DE 19575006C DE 19575006 I2 DE19575006 I2 DE 19575006I2
Authority
DE
Germany
Prior art keywords
group
octahydrobenzo
quinoline derivatives
pharmaceutical effect
quinoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE1995175006
Other languages
German (de)
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of DE19575006I2 publication Critical patent/DE19575006I2/de
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/08—Aza-anthracenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Luminescent Compositions (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Quinoline Compounds (AREA)
DE1995175006 1981-10-16 1982-10-06 1, 2, 3, 4a, 5, 10, 10a-Octahydrobenzo(g)chinolin-Derivate mit pharmazeutischer Wirkung Active DE19575006I2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH663181 1981-10-16
CH392782 1982-06-25

Publications (1)

Publication Number Publication Date
DE19575006I2 true DE19575006I2 (de) 2003-01-09

Family

ID=25694193

Family Applications (2)

Application Number Title Priority Date Filing Date
DE1995175006 Active DE19575006I2 (de) 1981-10-16 1982-10-06 1, 2, 3, 4a, 5, 10, 10a-Octahydrobenzo(g)chinolin-Derivate mit pharmazeutischer Wirkung
DE8282810413T Expired - Lifetime DE3280252D1 (de) 1981-10-16 1982-10-06 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)chinolin-derivate mit pharmazeutischer wirkung.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE8282810413T Expired - Lifetime DE3280252D1 (de) 1981-10-16 1982-10-06 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)chinolin-derivate mit pharmazeutischer wirkung.

Country Status (19)

Country Link
US (1) US4565818A (en:Method)
EP (1) EP0077754B1 (en:Method)
JP (1) JPH02138262A (en:Method)
AT (1) ATE56958T1 (en:Method)
AU (1) AU558375B2 (en:Method)
CA (1) CA1200241A (en:Method)
CY (1) CY1736A (en:Method)
DE (2) DE19575006I2 (en:Method)
DK (1) DK160820C (en:Method)
ES (3) ES516551A0 (en:Method)
FI (1) FI78908C (en:Method)
HK (1) HK107794A (en:Method)
HU (1) HU190703B (en:Method)
IE (1) IE56836B1 (en:Method)
IL (1) IL66987A (en:Method)
LU (1) LU88619I2 (en:Method)
NZ (1) NZ202169A (en:Method)
PH (1) PH22774A (en:Method)
PT (1) PT75679A (en:Method)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH22782A (en) * 1983-02-01 1988-12-12 Sandoz Ltd Novel pharmaceutical active 1,2,3,4,4a,5,10,10a octahydrobenzo(g)quinoline derivatives
AT393997B (de) * 1983-06-22 1992-01-10 Heidelberger Druckmasch Ag Vorrichtung zur entnahme von bedruckten bogen fuer deren begutachtung
NL8702680A (nl) * 1986-11-21 1988-06-16 Sandoz Ag Nieuwe benzogchinolinen en werkwijzen voor het bereiden en toepassen van deze verbindingen.
WO1990000896A1 (en) * 1988-07-22 1990-02-08 Sandoz Ag USE OF BENZO(g)QUINOLINES IN TREATMENT OF NICOTINE ADDICTION
GB8829330D0 (en) * 1988-12-16 1989-02-01 Sandoz Ltd Improvements in or relating to organic compounds
US5262422A (en) * 1991-05-02 1993-11-16 Sandoz Ltd. Octahydrobenzo[g]quinoline
DE4114325A1 (de) * 1991-05-02 1992-11-05 Sandoz Ag Octahydrobenzo(g)chinolin, seine herstellung und verwendung
US5264577A (en) * 1992-04-22 1993-11-23 Warner-Lambert Company Cyclic amino acids and derivatives thereof
GB9326010D0 (en) * 1993-12-21 1994-02-23 Sandoz Ltd Improvements in or relating to organic compounds
TW357143B (en) * 1995-07-07 1999-05-01 Novartis Ag Benzo[g]quinoline derivatives
TW378209B (en) * 1996-07-08 2000-01-01 Novartis Ag Benzo[g]quinoline derivatives, their preparation and the pharmaceutical composition containing them
US6187808B1 (en) 1998-07-28 2001-02-13 Warner-Lambert Company Hexahydro-naphthalenone oximes and hydrazones
US6380217B1 (en) * 1999-03-31 2002-04-30 Millennium Pharmaceuticals, Inc. Methods for controlling GGT-positive bacteria
SE0001438D0 (sv) 2000-04-18 2000-04-18 Axon Chemicals Bv New chemical compounds and their use in therapy
WO2006117608A1 (en) 2005-04-29 2006-11-09 Ferring International Center S.A. Treatment or prevention of ovarian hyperstimulation syndrome (ohss) using a dopamine agonist
JP2011525893A (ja) * 2008-06-27 2011-09-29 ハー・ルンドベック・アクチエゼルスカベット 新規のフェノールアミン類およびカテコールアミン類ならびにそのプロドラッグ
US8067410B2 (en) 2008-06-27 2011-11-29 H. Lundbeck A/S Phenolic and catecholic amines and prodrugs thereof
CR20200225A (es) 2017-11-24 2020-07-25 H Lundbeck As Nuevos fármacos de catecolamina para uso en el tratamiento de la enfermedad de parkinson
US11111263B2 (en) 2019-05-20 2021-09-07 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11130775B2 (en) 2019-05-20 2021-09-28 H. Lundbeck A/S Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11104697B2 (en) 2019-05-20 2021-08-31 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11168056B2 (en) 2019-05-20 2021-11-09 H. Lundbeck A/S Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diol
EP3972600B1 (en) 2019-05-21 2026-02-18 H. Lundbeck A/S Catecholamine carbamate prodrugs for use in the treatment of parkinson s disease
EP3972971A1 (en) 2019-05-21 2022-03-30 H. Lundbeck A/S New catecholamine prodrugs for use in the treatment of parkinson's diseases
JP7562562B2 (ja) 2019-05-21 2024-10-07 ハー・ルンドベック・アクチエゼルスカベット パーキンソン病の治療に使用するための新規なカテコールアミンプロドラッグ
JP7641234B2 (ja) 2019-05-21 2025-03-06 ハー・ルンドベック・アクチエゼルスカベット パーキンソン病の治療に使用するための新規なカテコールアミンプロドラッグ
WO2024153752A1 (en) * 2023-01-20 2024-07-25 Ferring B.V. Stereoselective synthesis of intermediates and synthesis of quinagolids

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839338A (en) * 1968-05-09 1974-10-01 W Michne 1,2,3,4,4A,5,10,10A-OCTAHYDROBENZO{8 g{9 QUINOLINES
US4100164A (en) * 1974-05-20 1978-07-11 Sterling Drug Inc. 2,6-Methano-3-benzazocines
US4169893A (en) * 1978-03-13 1979-10-02 Sandoz, Inc. 4-hydroxy-naphthpyridine-2(1h)-one-3-carboxylic acids and esters
US4235909A (en) * 1979-04-19 1980-11-25 Eli Lilly And Company Octahydro-2H-pyrrolo[3,4-g]quinolines
DE3063420D1 (en) * 1979-03-26 1983-07-07 Takeda Chemical Industries Ltd Tetrahydroisoquinolines, their production and the compounds and pharmaceutical compositions containing them for use in the prevention or treatment of hypertension

Also Published As

Publication number Publication date
IE822500L (en) 1983-04-16
JPH059430B2 (en:Method) 1993-02-04
JPH02138262A (ja) 1990-05-28
FI78908C (fi) 1989-10-10
FI78908B (fi) 1989-06-30
DK160820B (da) 1991-04-22
AU558375B2 (en) 1987-01-29
ES8706120A1 (es) 1987-06-01
ES526493A0 (es) 1986-04-16
US4565818A (en) 1986-01-21
FI823436L (fi) 1983-04-17
DK160820C (da) 1991-10-07
HU190703B (en) 1986-10-28
DE3280252D1 (de) 1990-10-31
ATE56958T1 (de) 1990-10-15
AU8936782A (en) 1983-04-21
LU88619I2 (fr) 1995-07-10
IE56836B1 (en) 1992-01-01
IL66987A0 (en) 1983-02-23
PH22774A (en) 1988-12-12
CA1200241A (en) 1986-02-04
ES526492A0 (es) 1987-06-01
DK457182A (da) 1983-04-17
NZ202169A (en) 1985-07-31
EP0077754B1 (en) 1990-09-26
IL66987A (en) 1986-11-30
ES8405373A1 (es) 1984-06-01
ES8606281A1 (es) 1986-04-16
PT75679A (en) 1982-11-01
EP0077754A2 (en) 1983-04-27
ES516551A0 (es) 1984-06-01
EP0077754A3 (en) 1985-05-22
HK107794A (en) 1994-10-14
FI823436A0 (fi) 1982-10-08
CY1736A (en) 1994-06-03

Similar Documents

Publication Publication Date Title
DE3280252D1 (de) 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)chinolin-derivate mit pharmazeutischer wirkung.
DE69516540D1 (de) AMINO-IMIDAZO [4,5-c] CHINOLINE
NO871727D0 (no) Fremgangsmaate for fremstilling av nye kinolinderivater.
NO872685D0 (no) Nye topisk appliserbare farmasoeytiske sammensetninger med systemisk virkning.
SE8400445D0 (sv) Novel pharmaceutical active 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)quinoline derivatives, their production and use
NO892543D0 (no) Fremgangsmaate for fremstilling av nye neplanocinderivater.
YU48671B (sh) Novi derivati beta-fenilizoserina, njegovo dobijanje i primena
NO881545L (no) Nye pyrrolidin-2-(1,3-dikarbonyl)-derivater, samt fremgangsmaate for fremstilling derav.
ES482138A1 (es) Procedimiento para la obtencion de 1-bencil -fenil-piperidi-nas.
ATE147742T1 (de) 8-alpha-acylamino-ergoline, ihre herstellung und verwendung als arzneimittel
IT1226045B (it) Derivati tetraidrochinolici
PT69327A (fr) Procede d'isomerisation des derives de la vinyl-3 piperidine
FI893570A7 (fi) Menetelmä lääkeaineina käyttökelpoisten 1H-imidatso/1,2-b/-pyratsolin johdannaisten valmistamiseksi
FI905325A7 (fi) Menetelmä bentsyylipyrrolidiinijohdannaisten valmistamiseksi, jotka ovat aktiivisia dopamiiniagonisteina
ES8301933A1 (es) "procedimiento para la preparacion de derivados de 4-(5)-alcohil-mercaptoimidazoles".
NO851868L (no) Fremgangsmaate for fremstilling av nye kinolinderivater.
FI931893L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 7,8-dihydroksi-1,2,5-oksa-, tia- ja seleenidiatsolo/3,4-f/kinoksaliinijohdannaisten valmistamiseksi
JPS53144578A (en) Pyridyl methyl derivatives